{"DataElement":{"publicId":"4188891","version":"1","preferredName":"Non-Steroidal Aromatase Inhibitor Resistance Process Patient Description","preferredDefinition":"Description of the setting in which the patient developed resistance to prior non-steroidal aromatase inhibitor (AI) treatment.","longName":"4188857v1.0:3775432v1.0","context":"ECOG-ACRIN","contextVersion":"1","DataElementConcept":{"publicId":"4188857","version":"1","preferredName":"Non-Steroidal Aromatase Inhibitor Resistance Process Patient Description","preferredDefinition":"Description of the setting in which the patient developed resistance to a non-steroidal aromatase inhibitor treatment.","longName":"4188855v1.0:2222846v1.0","context":"ECOG-ACRIN","contextVersion":"1","ObjectClass":{"publicId":"4188855","version":"1","preferredName":"Non-Steroidal Aromatase Inhibitor Resistance Process Patient","preferredDefinition":"An aromatase inhibitor with a non-steroidal structure. Non-steroidal aromatase inhibitors work by reversible competition with the enzyme.:A Resistance Process consists of activities of biologic molecules or complexes involved in processes that maintain immunity to, or counteract, defeat, or withstand the effects of, an antagonistic agent.:A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","longName":"C2018:C41546:C16960","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Non-Steroidal Aromatase Inhibitor","conceptCode":"C2018","definition":"An aromatase inhibitor with a non-steroidal structure. Non-steroidal aromatase inhibitors work by reversible competition with the enzyme.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Resistance Process","conceptCode":"C41546","definition":"A Resistance Process consists of activities of biologic molecules or complexes involved in processes that maintain immunity to, or counteract, defeat, or withstand the effects of, an antagonistic agent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F3CBCE04-4869-D6CB-E040-BB89AD430BE8","latestVersionIndicator":"Yes","beginDate":"2014-03-04","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-03-04","modifiedBy":"ONEDATA","dateModified":"2014-03-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2222846","version":"1","preferredName":"Description","preferredDefinition":"A statement or an account describing something.","longName":"C25365","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Description","conceptCode":"C25365","definition":"A written or verbal account, representation, statement, or explanation of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F6211337-E099-4E34-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-02","endDate":null,"createdBy":"UMLLOADER_EVS","dateCreated":"2005-05-02","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F3CBCE04-4877-D6CB-E040-BB89AD430BE8","latestVersionIndicator":"Yes","beginDate":"2014-03-04","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-03-04","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3775432","version":"1","preferredName":"Treatment Intent Type","preferredDefinition":"the description of a drug regimen or type of treatment given to a patient.","longName":"TX_INT_TP","context":"AECC","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":"0","PermissibleValues":[{"value":"None","valueDescription":"None","ValueMeaning":{"publicId":"2577064","version":"1","preferredName":"None","longName":"2577064","preferredDefinition":"No person or thing, nobody, not any.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"None","conceptCode":"C41132","definition":"No person or thing, nobody, not any.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FA15-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-22","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-22","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DE707859-4193-4C8B-E040-BB89AD432480","beginDate":"2013-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-06-05","modifiedBy":"ONEDATA","dateModified":"2013-06-05","deletedIndicator":"No"},{"value":"Adjuvant and Advanced","valueDescription":"Adjuvant And Advanced","ValueMeaning":{"publicId":"3775433","version":"1","preferredName":"Adjuvant And Advanced","longName":"3775433","preferredDefinition":"An agent that enhances the activity or therapeutic effect of another pharmacologic substance without having much, if any, therapeutic impact by itself.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: Far along in course.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adjuvant","conceptCode":"C2140","definition":"An agent that enhances the activity or therapeutic effect of another pharmacologic substance without having much, if any, therapeutic impact by itself.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Advanced","conceptCode":"C25411","definition":"Far along in course.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DE707859-41A1-4C8B-E040-BB89AD432480","latestVersionIndicator":"Yes","beginDate":"2013-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-06-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DE707859-41BA-4C8B-E040-BB89AD432480","beginDate":"2013-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-06-05","modifiedBy":"ONEDATA","dateModified":"2013-06-05","deletedIndicator":"No"},{"value":"Adjuvant","valueDescription":"Adjuvant","ValueMeaning":{"publicId":"3646981","version":"1","preferredName":"Adjuvant","longName":"3646981","preferredDefinition":"An agent that enhances the activity or therapeutic effect of another pharmacologic substance without having much, if any, therapeutic impact by itself.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adjuvant","conceptCode":"C2140","definition":"An agent that enhances the activity or therapeutic effect of another pharmacologic substance without having much, if any, therapeutic impact by itself.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D14DFDD1-5678-EDDE-E040-BB89AD430C11","latestVersionIndicator":"Yes","beginDate":"2012-12-20","endDate":null,"createdBy":"MAESKEB","dateCreated":"2012-12-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DE707859-41C4-4C8B-E040-BB89AD432480","beginDate":"2002-10-08","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-06-05","modifiedBy":"ONEDATA","dateModified":"2013-06-05","deletedIndicator":"No"},{"value":"Advanced","valueDescription":"ADVANCED","ValueMeaning":{"publicId":"2562598","version":"1","preferredName":"ADVANCED","longName":"2562598","preferredDefinition":"ADVANCED","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Advanced","conceptCode":"C25411","definition":"Far along in course.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C193-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-10-08","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-10-08","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DE707859-41CE-4C8B-E040-BB89AD432480","beginDate":"2002-10-08","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-06-05","modifiedBy":"ONEDATA","dateModified":"2013-06-05","deletedIndicator":"No"},{"value":"Neoadjuvant","valueDescription":"Neoadjuvant Therapy","ValueMeaning":{"publicId":"2580142","version":"1","preferredName":"Neoadjuvant Therapy","longName":"2580142","preferredDefinition":"Treatment designed to be used as a first step toward shrinking the cancer and in evaluating response to drugs and other agents. Induction therapy is followed by additional therapy to eliminate whatever cancer remains.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoadjuvant Therapy","conceptCode":"C15665","definition":"Therapy administered prior to the primary treatment for the purpose of making the primary treatment more effective.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-061B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-07-03","modifiedBy":"ONEDATA","dateModified":"2006-07-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DE707859-41D8-4C8B-E040-BB89AD432480","beginDate":"2002-10-08","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-06-05","modifiedBy":"ONEDATA","dateModified":"2013-06-05","deletedIndicator":"No"},{"value":"Locally advanced unresectable disease","valueDescription":"Advanced Unresectable Localized Disease","ValueMeaning":{"publicId":"3860591","version":"1","preferredName":"Advanced Unresectable Localized Disease","longName":"3860591","preferredDefinition":"Far along in course.: Unable to be removed with surgery.: A disease that is confined to a specific organ or tissue and has not spread to other anatomic sites.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Advanced","conceptCode":"C25411","definition":"Far along in course.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Unresectable","conceptCode":"C14151","definition":"Not capable of being removed by surgery.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Localized Disease","conceptCode":"C36162","definition":"A disease that is confined to a specific organ or tissue and has not spread to other anatomic sites.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E46856E3-672F-F78A-E040-BB89AD433250","latestVersionIndicator":"Yes","beginDate":"2013-08-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-08-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E46856E3-6748-F78A-E040-BB89AD433250","beginDate":"2013-08-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-08-20","modifiedBy":"ONEDATA","dateModified":"2013-08-20","deletedIndicator":"No"},{"value":"Metastatic","valueDescription":"Metastatic","ValueMeaning":{"publicId":"3438544","version":"1","preferredName":"Metastatic","longName":"3438544","preferredDefinition":"A term referring to the clinical or pathologic observation of a tumor extension from its original site of growth to another anatomic site.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metastatic","conceptCode":"C14174","definition":"A term referring to the clinical or pathologic observation of a tumor extension from its original site of growth to another anatomic site.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BDF7A8D0-B86E-5F0A-E040-BB89AD434D34","latestVersionIndicator":"Yes","beginDate":"2012-04-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E46856E3-6752-F78A-E040-BB89AD433250","beginDate":"2013-08-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-08-20","modifiedBy":"ONEDATA","dateModified":"2013-08-20","deletedIndicator":"No"},{"value":"Locally advanced/metastatic","valueDescription":"Locally advanced or metastatic disease","ValueMeaning":{"publicId":"4213257","version":"1","preferredName":"Locally advanced or metastatic disease","longName":"4213257","preferredDefinition":"Cancer that has spread from where it started to nearby tissue or lymph nodes.: Having to do with metastasis, which is the spread of cancer from the primary site (place where it started) to other places in the body.: Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Locally Advanced Malignant Neoplasm","conceptCode":"C8524","definition":"A malignant neoplasm that has spread from its original site of growth to nearby tissues or lymph nodes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Metastatic","conceptCode":"C14174","definition":"A term referring to the clinical or pathologic observation of a tumor extension from its original site of growth to another anatomic site.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F46AB1AA-68F8-DBC4-E040-BB89AD43166B","latestVersionIndicator":"Yes","beginDate":"2014-03-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-03-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F46AB1AA-6911-DBC4-E040-BB89AD43166B","beginDate":"2014-03-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-03-12","modifiedBy":"ONEDATA","dateModified":"2014-03-12","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DE707859-4180-4C8B-E040-BB89AD432480","latestVersionIndicator":"Yes","beginDate":"2013-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2013-06-05","modifiedBy":"REEVESD","dateModified":"2014-03-12","changeDescription":"AECC 8853 06.12.13 ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Setting in which patient deve","type":"Preferred Question Text","description":"Setting in which patient developed resistance to prior non steroidal AI treatment","url":null,"context":"ECOG-ACRIN"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F3CDFFE2-5CA1-7991-E040-BB89AD43762C","latestVersionIndicator":"Yes","beginDate":"2014-03-04","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-03-04","modifiedBy":"ROUILLAS","dateModified":"2014-03-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}